Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.00 | 26.62 |
| PEG Ratio (TTM) | 0.08 | -1.97 |
| P/S Ratio (TTM) | 0.24 | 2.04 |
| P/B Ratio (TTM) | 0.72 | 2.19 |
| P/FCF Ratio (TTM) | 3.86 | 15.02 |
| Price to 5YR AVG Earnings Ratio | -19.36 | 10.72 |
| Price to 5YR AVG FCF Ratio | 0.00 | 24.74 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.40% | 5.79% |
| ROE (TTM) | 4.61% | 11.11% |
| Net Profit Margin (TTM) | 1.48% | 7.05% |
| ROIC 5YR AVG | -3.38% | 9.79% |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 811.89% | 18.07% | -323.47% |
| Revenue | 4.85% | -33.97% | 39.04% |
| Net Income | 805.65% | 21.10% | -318.67% |
| Cash Flow | 853.77% | -40,448,068.46% | -24,268,837.24% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.65 | 1.40 |
| Quick Ratio (TTM) | 1.68 | 0.81 |
| D/E Ratio (TTM) | 0.14 | 0.84 |
| Interest Coverage (TTM) | 2.58 | 10.84 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 4.93 | 3.28 |
| LTL to 5YR AVG FCF | N/A | 6.77 |
| Shares Outstanding Growth 5YR AVG | 0.50% | 1.79% |